Apellis Pharmaceuticals Inc (APLS)
47.51
-0.52
(-1.08%)
USD |
NASDAQ |
Apr 18, 16:00
46.57
-0.94
(-1.98%)
After-Hours: 04:39
Apellis Pharmaceuticals Max Drawdown (5Y): 74.65% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 74.65% |
| February 29, 2024 | 74.65% |
| January 31, 2024 | 74.65% |
| December 31, 2023 | 74.65% |
| November 30, 2023 | 74.65% |
| October 31, 2023 | 74.65% |
| September 30, 2023 | 74.65% |
| August 31, 2023 | 74.65% |
| July 31, 2023 | 72.40% |
| June 30, 2023 | 61.77% |
| May 31, 2023 | 61.77% |
| April 30, 2023 | 61.77% |
| March 31, 2023 | 61.77% |
| February 28, 2023 | 61.77% |
| January 31, 2023 | 61.77% |
| December 31, 2022 | 61.77% |
| November 30, 2022 | 61.77% |
| October 31, 2022 | 61.77% |
| September 30, 2022 | 61.77% |
| August 31, 2022 | 61.77% |
| July 31, 2022 | 61.77% |
| June 30, 2022 | 61.77% |
| May 31, 2022 | 61.77% |
| April 30, 2022 | 61.77% |
| March 31, 2022 | 61.77% |
| Date | Value |
|---|---|
| February 28, 2022 | 61.77% |
| January 31, 2022 | 61.77% |
| December 31, 2021 | 61.77% |
| November 30, 2021 | 61.77% |
| October 31, 2021 | 61.77% |
| September 30, 2021 | 61.77% |
| August 31, 2021 | 61.77% |
| July 31, 2021 | 61.77% |
| June 30, 2021 | 61.77% |
| May 31, 2021 | 61.77% |
| April 30, 2021 | 61.77% |
| March 31, 2021 | 61.77% |
| February 28, 2021 | 61.77% |
| January 31, 2021 | 61.77% |
| December 31, 2020 | 61.77% |
| November 30, 2020 | 61.77% |
| October 31, 2020 | 61.77% |
| September 30, 2020 | 61.77% |
| August 31, 2020 | 61.77% |
| July 31, 2020 | 61.77% |
| June 30, 2020 | 61.77% |
| May 31, 2020 | 61.77% |
| April 30, 2020 | 61.77% |
| March 31, 2020 | 61.77% |
| February 29, 2020 | 61.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.77%
Minimum
Apr 2019
74.65%
Maximum
Aug 2023
63.66%
Average
61.77%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
| Sarepta Therapeutics Inc | 64.93% |
| Blueprint Medicines Corp | 69.50% |
| Alnylam Pharmaceuticals Inc | 54.98% |
| Ionis Pharmaceuticals Inc | 70.27% |
| Madrigal Pharmaceuticals Inc | 82.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 11.18 |
| Beta (5Y) | 0.882 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 73.71% |
| Historical Sharpe Ratio (5Y) | 0.3079 |
| Historical Sortino (5Y) | 0.4156 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.37% |